ZADITEN 1 MG 30TAB; ketotifen, respiratory tract agents .
ACTIVE-INGREDIENT OF ZADITEN 1 MG 30TAB
Zaditen tablets contain the equivalent of 1 mg Ketotifen ( as the hydrogen fumerate ).
INDICATION OF ZADITEN 1 MG 30TAB
Preventative treatment of bronchial asthma especially when associated with atopic symptoms. Zaditen is not effective in aborting established attacks of asthma. Zaditen is not a substitute for corticosteroid treatment (inhaled or systemic) when corticosteroid is indicated in the treatment of asthma. Prevention and treatment of multisystem allergic disorders ( chronic urticaria, atopic dermatitis, allergic rhinitis and conjunctives ).
DOSAGE OF ZADITEN 1 MG 30TAB
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
Use in adults: Zaditen tablet (1 gm) twice daily (with morning and evening meals). In patients susceptible to sedation, a slow increase in dose is recommended during the first week of treatment , starting with 1/2 tablet twice daily and increasing to the full therapeutic dose. If necessary , the daily dose may be increased up to 4 mg. i.e. 2 Zaditen tablets twice daily. At the higher dose, an accelerated onset of efficacy may be expected. Use in children : Clinical observations reflect pharmacokinetic findings and indicate that children may require a dosage regimen similar to adults in order to obtain optimal results ( see section CLINICAL PHARMACOLOGY ).
OVER-DOSAGE OF ZADITEN 1 MG 30TAB
Sings and symptoms : The main symptoms of acute overdose include: drowsiness to severe sedation; confusion and disorientation ; tachycardia and hypotension; especially in children, hyperexcitability or convulsions; reversible coma. Treatment : treatment should be symptomatic. If excitation or convulsions are present, short-acting barbiturates or benzodiazepines may be given. Monitoring of the cardiovascular system is recommended. If the drug has been taken very recently, emptying of the stomach may be considered. Adminstration of activated charcoal may be beneficial.
CONTRA-INDICATION OF ZADITEN 1 MG 30TAB
Known hypersensitivity to Ketotifen or any of the excipients ( see section EXCIPIENTS). Epilepcy or history of seizures ( see section WARNINGS AND PRECAUTIONS ).
STORAGE OF ZADITEN 1 MG 30TAB
See folding box. Zaditen should not be used after the data marked ʺEXPʺ on the pack. Zaditen should be kept out of the reach and sight of children .
PACK OF ZADITEN 1 MG 30TAB
ZADITEN 1 MG 30TAB MANUFACTURED BY
Novartis Pharma SAE under license of Novartis Pharma AG Basel Switzerland.